Blood tau markers may reflect brain changes associated with Alzheimer's disease
A review links blood tau measurements with brain tau pathology, while leaving diagnostic accuracy and practical clinical value unresolved.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review reports that higher levels of certain tau markers in blood consistently reflected tau pathology in the brain. This supports further study of blood measurements as markers of that pathology. It does not establish that testing improves diagnosis, treatment outcomes, or monitoring in routine care; the authors call for longer-term validation.
The abstract gives no study count, participant characteristics, pooled association estimates, or measures of diagnostic accuracy. It therefore cannot show how reliably a test distinguishes individuals with and without the relevant brain changes.
The question behind the marker
Researchers examined whether tau measured in blood corresponds to evidence of tau pathology in the brain, particularly findings from tau PET imaging. This addresses the relationship between biological measurements and their possible use as markers.
What remains to be validated
The authors propose blood tau as a potentially accessible tool for early detection and disease monitoring. They also call for larger studies following people over time, leaving the practical value of that proposal unresolved.
The original publication
Blood-Based Tau as a Biomarker for Early Detection and Monitoring of Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Kim KY, Shin KY, Chang KA
Int J Mol Sci · 2025
- PubMed ID
- 41226373
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.